nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—CES1—Capecitabine—breast cancer	0.239	0.413	CbGbCtD
Trandolapril—CES1—Tamoxifen—breast cancer	0.193	0.332	CbGbCtD
Trandolapril—CES1—Irinotecan—breast cancer	0.148	0.255	CbGbCtD
Trandolapril—ACE—umbilical vein—breast cancer	0.00621	0.143	CbGeAlD
Trandolapril—ACE—arm—breast cancer	0.00543	0.125	CbGeAlD
Trandolapril—CES1—Irinotecan Pathway—SLCO1B1—breast cancer	0.00453	0.0592	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—ABCC1—breast cancer	0.00332	0.0433	CbGpPWpGaD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—breast cancer	0.0028	0.0366	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—CDA—breast cancer	0.00237	0.031	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—ABCG2—breast cancer	0.0023	0.03	CbGpPWpGaD
Trandolapril—SLC15A2—mammary gland—breast cancer	0.00207	0.0476	CbGeAlD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—breast cancer	0.00203	0.0266	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—AGTR2—breast cancer	0.00202	0.0264	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—BCHE—breast cancer	0.0019	0.0249	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—XRCC3—breast cancer	0.00187	0.0245	CbGpPWpGaD
Trandolapril—SLC15A1—epithelium—breast cancer	0.00184	0.0424	CbGeAlD
Trandolapril—CES1—E2F transcription factor network—HIC1—breast cancer	0.00181	0.0237	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—UMPS—breast cancer	0.0018	0.0235	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—CYP3A4—breast cancer	0.00177	0.0232	CbGpPWpGaD
Trandolapril—SLC15A1—endometrium—breast cancer	0.00165	0.0381	CbGeAlD
Trandolapril—ACE—embryo—breast cancer	0.00162	0.0373	CbGeAlD
Trandolapril—CES1—adipose tissue—breast cancer	0.00161	0.037	CbGeAlD
Trandolapril—ACE—ACE Inhibitor Pathway—AGTR1—breast cancer	0.00156	0.0203	CbGpPWpGaD
Trandolapril—CES1—female reproductive system—breast cancer	0.00148	0.034	CbGeAlD
Trandolapril—CES1—adrenal gland—breast cancer	0.00144	0.0332	CbGeAlD
Trandolapril—CES1—female gonad—breast cancer	0.00134	0.0309	CbGeAlD
Trandolapril—ACE—epithelium—breast cancer	0.00132	0.0304	CbGeAlD
Trandolapril—CES1—endocrine gland—breast cancer	0.00125	0.0287	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—DPYD—breast cancer	0.00124	0.0163	CbGpPWpGaD
Trandolapril—ACE—endometrium—breast cancer	0.00119	0.0273	CbGeAlD
Trandolapril—SLC15A1—endocrine gland—breast cancer	0.00116	0.0267	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—ABCG2—breast cancer	0.00116	0.0151	CbGpPWpGaD
Trandolapril—ACE—pituitary gland—breast cancer	0.00107	0.0247	CbGeAlD
Trandolapril—ACE—adipose tissue—breast cancer	0.00107	0.0246	CbGeAlD
Trandolapril—CES1—Irinotecan Pathway—APC—breast cancer	0.00103	0.0135	CbGpPWpGaD
Trandolapril—SLC15A2—endometrium—breast cancer	0.00103	0.0238	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—INHBB—breast cancer	0.00101	0.0132	CbGpPWpGaD
Trandolapril—ACE—female reproductive system—breast cancer	0.000982	0.0226	CbGeAlD
Trandolapril—ACE—adrenal gland—breast cancer	0.000958	0.0221	CbGeAlD
Trandolapril—CES1—NRF2 pathway—SLC2A10—breast cancer	0.000952	0.0124	CbGpPWpGaD
Trandolapril—SLC15A2—pituitary gland—breast cancer	0.000935	0.0215	CbGeAlD
Trandolapril—ACE—bone marrow—breast cancer	0.000927	0.0213	CbGeAlD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.000916	0.012	CbGpPWpGaD
Trandolapril—ACE—female gonad—breast cancer	0.000893	0.0206	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—SMUG1—breast cancer	0.000886	0.0116	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—ALDH3A1—breast cancer	0.000885	0.0116	CbGpPWpGaD
Trandolapril—CES1—lymph node—breast cancer	0.000863	0.0199	CbGeAlD
Trandolapril—SLC15A2—female reproductive system—breast cancer	0.000856	0.0197	CbGeAlD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00085	0.0111	CbGpPWpGaD
Trandolapril—SLC15A2—adrenal gland—breast cancer	0.000835	0.0192	CbGeAlD
Trandolapril—ACE—endocrine gland—breast cancer	0.000831	0.0191	CbGeAlD
Trandolapril—ACE—ACE Inhibitor Pathway—NOS3—breast cancer	0.000803	0.0105	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC39A7—breast cancer	0.000789	0.0103	CbGpPWpGaD
Trandolapril—SLC15A2—female gonad—breast cancer	0.000779	0.0179	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—MME—breast cancer	0.000736	0.00963	CbGpPWpGaD
Trandolapril—SLC15A2—endocrine gland—breast cancer	0.000724	0.0167	CbGeAlD
Trandolapril—CES1—E2F transcription factor network—XRCC1—breast cancer	0.000721	0.00943	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—TYMS—breast cancer	0.000709	0.00927	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC2A5—breast cancer	0.000694	0.00907	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—ERCC2—breast cancer	0.000659	0.00862	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—MTHFR—breast cancer	0.00062	0.0081	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC39A6—breast cancer	0.000598	0.00781	CbGpPWpGaD
Trandolapril—Perindopril—BCHE—breast cancer	0.000594	0.184	CrCbGaD
Trandolapril—ACE—lymph node—breast cancer	0.000574	0.0132	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—ACHE—breast cancer	0.000565	0.00738	CbGpPWpGaD
Trandolapril—Benazepril—MTHFR—breast cancer	0.00056	0.174	CrCbGaD
Trandolapril—CES1—E2F transcription factor network—CASP7—breast cancer	0.000544	0.00711	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—CTSD—breast cancer	0.000535	0.00699	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—TGFB1—breast cancer	0.000531	0.00694	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA3—breast cancer	0.000508	0.00664	CbGpPWpGaD
Trandolapril—Ramipril—BCHE—breast cancer	0.000507	0.157	CrCbGaD
Trandolapril—SLC15A2—lymph node—breast cancer	0.000501	0.0115	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—BCHE—breast cancer	0.000492	0.00643	CbGpPWpGaD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000471	0.00616	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA4—breast cancer	0.000465	0.00607	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—TCF7L2—breast cancer	0.000458	0.00598	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA2—breast cancer	0.000453	0.00592	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GPX2—breast cancer	0.000453	0.00592	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000447	0.00585	CbGpPWpGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000437	0.00571	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—BRCA1—breast cancer	0.000437	0.00571	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTA1—breast cancer	0.000437	0.00571	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000415	0.00543	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000409	0.00535	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000409	0.00535	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—SIRT1—breast cancer	0.000388	0.00507	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CCNE1—breast cancer	0.000383	0.005	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.00038	0.00496	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.00038	0.00496	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—TYMS—breast cancer	0.000376	0.00491	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—E2F1—breast cancer	0.00036	0.0047	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC2A2—breast cancer	0.00036	0.0047	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000339	0.00443	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGFBP5—breast cancer	0.000331	0.00433	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000315	0.00411	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFB2—breast cancer	0.000314	0.0041	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.00031	0.00405	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CDK2—breast cancer	0.00031	0.00405	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—PLAU—breast cancer	0.00031	0.00405	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EEF1B2—breast cancer	0.000303	0.00396	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000299	0.0039	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000299	0.0039	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SQSTM1—breast cancer	0.000297	0.00388	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—LEP—breast cancer	0.000296	0.00387	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—ATM—breast cancer	0.000294	0.00385	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC5A5—breast cancer	0.000288	0.00377	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000288	0.00376	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC2A1—breast cancer	0.000278	0.00364	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—NQO1—breast cancer	0.000278	0.00364	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000277	0.00363	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000277	0.00362	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000277	0.00362	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—HSP90AA1—breast cancer	0.000262	0.00342	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—EGR1—breast cancer	0.000259	0.00338	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000257	0.00337	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000257	0.00336	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—RB1—breast cancer	0.000255	0.00333	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—IGF1—breast cancer	0.000245	0.0032	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—SERPINE1—breast cancer	0.00024	0.00314	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000239	0.00312	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—TP53—breast cancer	0.000235	0.00308	CbGpPWpGaD
Trandolapril—Perindopril—ABCB1—breast cancer	0.000233	0.0722	CrCbGaD
Trandolapril—CES1—NRF2 pathway—GSTP1—breast cancer	0.000232	0.00304	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFBR2—breast cancer	0.000232	0.00304	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ATF4—breast cancer	0.00023	0.003	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—HMOX1—breast cancer	0.000229	0.00299	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000227	0.00297	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—HGF—breast cancer	0.000213	0.00279	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTM1—breast cancer	0.000213	0.00279	CbGpPWpGaD
Trandolapril—Nateglinide—PTGS1—breast cancer	0.000212	0.0656	CrCbGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000211	0.00276	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—NRG1—breast cancer	0.000209	0.00274	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000208	0.00272	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000208	0.00272	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF2S2—breast cancer	0.000207	0.0027	CbGpPWpGaD
Trandolapril—Cilazapril—ABCB1—breast cancer	0.000205	0.0637	CrCbGaD
Trandolapril—Lisinopril—ABCB1—breast cancer	0.000205	0.0637	CrCbGaD
Trandolapril—CES1—E2F transcription factor network—CDKN1B—breast cancer	0.000198	0.00259	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000193	0.00252	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000193	0.00252	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CCT5—breast cancer	0.00019	0.00249	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—INHBB—breast cancer	0.00019	0.00249	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CDKN1A—breast cancer	0.000183	0.00239	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—CTNNB1—breast cancer	0.000181	0.00237	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EEF2—breast cancer	0.000181	0.00237	CbGpPWpGaD
Trandolapril—Enalapril—CYP3A4—breast cancer	0.000181	0.0561	CrCbGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000172	0.00225	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000172	0.00225	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPL31—breast cancer	0.000171	0.00223	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—COX11—breast cancer	0.00016	0.00209	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.00016	0.00209	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPS4X—breast cancer	0.000159	0.00208	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000158	0.00206	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF3A—breast cancer	0.000157	0.00205	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—DDIT3—breast cancer	0.000157	0.00205	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000155	0.00202	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ADAMTS1—breast cancer	0.000152	0.00199	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—MYC—breast cancer	0.000152	0.00198	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000152	0.00198	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000152	0.00198	CbGpPWpGaD
Trandolapril—Enalapril—ABCB1—breast cancer	0.000151	0.0467	CrCbGaD
Trandolapril—ACE—Metabolism of proteins—MUC2—breast cancer	0.000148	0.00193	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000146	0.00191	CbGpPWpGaD
Trandolapril—Nateglinide—CYP2D6—breast cancer	0.000144	0.0447	CrCbGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000143	0.00188	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000141	0.00184	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000141	0.00184	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PABPC1—breast cancer	0.000141	0.00184	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MME—breast cancer	0.000139	0.00182	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—TUBB3—breast cancer	0.000137	0.0018	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000131	0.00171	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPL23A—breast cancer	0.000129	0.00169	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000124	0.00162	CbGpPWpGaD
Trandolapril—Nateglinide—CYP3A4—breast cancer	0.000123	0.0383	CrCbGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000121	0.00158	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPS8—breast cancer	0.000121	0.00158	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPS7—breast cancer	0.000121	0.00158	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.00012	0.00156	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000119	0.00156	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000115	0.0015	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000111	0.00145	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000111	0.00145	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000111	0.00145	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGFBP3—breast cancer	0.000109	0.00143	CbGpPWpGaD
Trandolapril—Nateglinide—ALB—breast cancer	0.000108	0.0334	CrCbGaD
Trandolapril—ACE—Metabolism of proteins—ACHE—breast cancer	0.000107	0.00139	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000103	0.00135	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CTSD—breast cancer	0.000101	0.00132	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—THBS1—breast cancer	9.94e-05	0.0013	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	9.44e-05	0.00123	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—BCHE—breast cancer	9.29e-05	0.00121	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—RPS6—breast cancer	9.06e-05	0.00118	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	8.76e-05	0.00115	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFB1—breast cancer	8.7e-05	0.00114	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—TCF7L2—breast cancer	8.64e-05	0.00113	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PLAUR—breast cancer	8.08e-05	0.00106	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PLG—breast cancer	7.9e-05	0.00103	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	7.86e-05	0.00103	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	7.7e-05	0.00101	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	7.29e-05	0.000953	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	7.14e-05	0.000934	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	6.86e-05	0.000897	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	6.6e-05	0.000863	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	6.37e-05	0.000832	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.3e-05	0.000823	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	6.13e-05	0.000801	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.08e-05	0.000795	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	5.91e-05	0.000773	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	5.85e-05	0.000764	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MMP1—breast cancer	5.77e-05	0.000755	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	5.65e-05	0.000738	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—LEP—breast cancer	5.59e-05	0.00073	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	5.56e-05	0.000727	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	5.49e-05	0.000717	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	5.42e-05	0.000709	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	5.16e-05	0.000675	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	5.03e-05	0.000658	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	5e-05	0.000654	CbGpPWpGaD
Trandolapril—Eye disorder—Epirubicin—breast cancer	5e-05	0.000168	CcSEcCtD
Trandolapril—Tinnitus—Epirubicin—breast cancer	4.99e-05	0.000168	CcSEcCtD
Trandolapril—Malnutrition—Methotrexate—breast cancer	4.98e-05	0.000168	CcSEcCtD
Trandolapril—Headache—Gemcitabine—breast cancer	4.97e-05	0.000168	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Capecitabine—breast cancer	4.97e-05	0.000167	CcSEcCtD
Trandolapril—Cardiac disorder—Epirubicin—breast cancer	4.96e-05	0.000167	CcSEcCtD
Trandolapril—Flushing—Epirubicin—breast cancer	4.96e-05	0.000167	CcSEcCtD
Trandolapril—Vomiting—Fluorouracil—breast cancer	4.96e-05	0.000167	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—breast cancer	4.96e-05	0.000167	CcSEcCtD
Trandolapril—Dyspepsia—Docetaxel—breast cancer	4.96e-05	0.000167	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—breast cancer	4.95e-05	0.000167	CcSEcCtD
Trandolapril—Insomnia—Capecitabine—breast cancer	4.93e-05	0.000166	CcSEcCtD
Trandolapril—Rash—Fluorouracil—breast cancer	4.92e-05	0.000166	CcSEcCtD
Trandolapril—Dermatitis—Fluorouracil—breast cancer	4.92e-05	0.000166	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—breast cancer	4.91e-05	0.000166	CcSEcCtD
Trandolapril—Paraesthesia—Capecitabine—breast cancer	4.9e-05	0.000165	CcSEcCtD
Trandolapril—Decreased appetite—Docetaxel—breast cancer	4.9e-05	0.000165	CcSEcCtD
Trandolapril—Hypersensitivity—Paclitaxel—breast cancer	4.9e-05	0.000165	CcSEcCtD
Trandolapril—Headache—Fluorouracil—breast cancer	4.89e-05	0.000165	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—breast cancer	4.89e-05	0.000165	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—breast cancer	4.88e-05	0.000164	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—breast cancer	4.87e-05	0.000164	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Docetaxel—breast cancer	4.86e-05	0.000164	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—breast cancer	4.86e-05	0.000164	CcSEcCtD
Trandolapril—Dyspnoea—Capecitabine—breast cancer	4.86e-05	0.000164	CcSEcCtD
Trandolapril—Fatigue—Docetaxel—breast cancer	4.86e-05	0.000164	CcSEcCtD
Trandolapril—Angiopathy—Epirubicin—breast cancer	4.85e-05	0.000164	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—breast cancer	4.85e-05	0.000163	CcSEcCtD
Trandolapril—Nausea—Mitoxantrone—breast cancer	4.84e-05	0.000163	CcSEcCtD
Trandolapril—Nausea—Irinotecan—breast cancer	4.84e-05	0.000163	CcSEcCtD
Trandolapril—Immune system disorder—Epirubicin—breast cancer	4.83e-05	0.000163	CcSEcCtD
Trandolapril—Mediastinal disorder—Epirubicin—breast cancer	4.82e-05	0.000162	CcSEcCtD
Trandolapril—Constipation—Docetaxel—breast cancer	4.82e-05	0.000162	CcSEcCtD
Trandolapril—Back pain—Methotrexate—breast cancer	4.81e-05	0.000162	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	4.8e-05	0.000628	CbGpPWpGaD
Trandolapril—Dyspepsia—Capecitabine—breast cancer	4.8e-05	0.000162	CcSEcCtD
Trandolapril—Arrhythmia—Epirubicin—breast cancer	4.78e-05	0.000161	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—breast cancer	4.77e-05	0.000161	CcSEcCtD
Trandolapril—Asthenia—Paclitaxel—breast cancer	4.77e-05	0.000161	CcSEcCtD
Trandolapril—Decreased appetite—Capecitabine—breast cancer	4.74e-05	0.00016	CcSEcCtD
Trandolapril—Alopecia—Epirubicin—breast cancer	4.73e-05	0.000159	CcSEcCtD
Trandolapril—Nausea—Gemcitabine—breast cancer	4.72e-05	0.000159	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Capecitabine—breast cancer	4.71e-05	0.000159	CcSEcCtD
Trandolapril—Fatigue—Capecitabine—breast cancer	4.7e-05	0.000158	CcSEcCtD
Trandolapril—Pruritus—Paclitaxel—breast cancer	4.7e-05	0.000158	CcSEcCtD
Trandolapril—Mental disorder—Epirubicin—breast cancer	4.69e-05	0.000158	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—breast cancer	4.68e-05	0.000158	CcSEcCtD
Trandolapril—Constipation—Capecitabine—breast cancer	4.66e-05	0.000157	CcSEcCtD
Trandolapril—Malnutrition—Epirubicin—breast cancer	4.66e-05	0.000157	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	4.64e-05	0.000607	CbGpPWpGaD
Trandolapril—Feeling abnormal—Docetaxel—breast cancer	4.64e-05	0.000156	CcSEcCtD
Trandolapril—Nausea—Fluorouracil—breast cancer	4.64e-05	0.000156	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—breast cancer	4.62e-05	0.000156	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—IGF1—breast cancer	4.62e-05	0.000603	CbGpPWpGaD
Trandolapril—Ill-defined disorder—Methotrexate—breast cancer	4.62e-05	0.000156	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—breast cancer	4.61e-05	0.000155	CcSEcCtD
Trandolapril—Gastrointestinal pain—Docetaxel—breast cancer	4.61e-05	0.000155	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—breast cancer	4.6e-05	0.000155	CcSEcCtD
Trandolapril—Flushing—Doxorubicin—breast cancer	4.59e-05	0.000155	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—breast cancer	4.59e-05	0.000155	CcSEcCtD
Trandolapril—Flatulence—Epirubicin—breast cancer	4.59e-05	0.000155	CcSEcCtD
Trandolapril—Dysgeusia—Epirubicin—breast cancer	4.56e-05	0.000154	CcSEcCtD
Trandolapril—Diarrhoea—Paclitaxel—breast cancer	4.55e-05	0.000153	CcSEcCtD
Trandolapril—Back pain—Epirubicin—breast cancer	4.5e-05	0.000152	CcSEcCtD
Trandolapril—Feeling abnormal—Capecitabine—breast cancer	4.49e-05	0.000151	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—breast cancer	4.49e-05	0.000151	CcSEcCtD
Trandolapril—Malaise—Methotrexate—breast cancer	4.49e-05	0.000151	CcSEcCtD
Trandolapril—Muscle spasms—Epirubicin—breast cancer	4.48e-05	0.000151	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—breast cancer	4.47e-05	0.000151	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—breast cancer	4.47e-05	0.000151	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—MMP2—breast cancer	4.47e-05	0.000584	CbGpPWpGaD
Trandolapril—Gastrointestinal pain—Capecitabine—breast cancer	4.46e-05	0.00015	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—breast cancer	4.46e-05	0.00015	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	4.46e-05	0.000583	CbGpPWpGaD
Trandolapril—Body temperature increased—Docetaxel—breast cancer	4.45e-05	0.00015	CcSEcCtD
Trandolapril—Abdominal pain—Docetaxel—breast cancer	4.45e-05	0.00015	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—breast cancer	4.45e-05	0.00015	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—breast cancer	4.42e-05	0.000149	CcSEcCtD
Trandolapril—Dizziness—Paclitaxel—breast cancer	4.4e-05	0.000148	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—breast cancer	4.37e-05	0.000147	CcSEcCtD
Trandolapril—Cough—Methotrexate—breast cancer	4.34e-05	0.000146	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—breast cancer	4.34e-05	0.000146	CcSEcCtD
Trandolapril—Urticaria—Capecitabine—breast cancer	4.33e-05	0.000146	CcSEcCtD
Trandolapril—Ill-defined disorder—Epirubicin—breast cancer	4.32e-05	0.000146	CcSEcCtD
Trandolapril—Body temperature increased—Capecitabine—breast cancer	4.31e-05	0.000145	CcSEcCtD
Trandolapril—Abdominal pain—Capecitabine—breast cancer	4.31e-05	0.000145	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—breast cancer	4.31e-05	0.000145	CcSEcCtD
Trandolapril—Anaemia—Epirubicin—breast cancer	4.3e-05	0.000145	CcSEcCtD
Trandolapril—Agitation—Epirubicin—breast cancer	4.28e-05	0.000144	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—breast cancer	4.25e-05	0.000143	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—breast cancer	4.24e-05	0.000143	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—breast cancer	4.24e-05	0.000143	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—breast cancer	4.24e-05	0.000143	CcSEcCtD
Trandolapril—Vomiting—Paclitaxel—breast cancer	4.23e-05	0.000142	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—breast cancer	4.22e-05	0.000142	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.21e-05	0.000142	CcSEcCtD
Trandolapril—Malaise—Epirubicin—breast cancer	4.2e-05	0.000141	CcSEcCtD
Trandolapril—Rash—Paclitaxel—breast cancer	4.19e-05	0.000141	CcSEcCtD
Trandolapril—Dermatitis—Paclitaxel—breast cancer	4.19e-05	0.000141	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—breast cancer	4.18e-05	0.000141	CcSEcCtD
Trandolapril—Vertigo—Epirubicin—breast cancer	4.18e-05	0.000141	CcSEcCtD
Trandolapril—Syncope—Epirubicin—breast cancer	4.18e-05	0.000141	CcSEcCtD
Trandolapril—Leukopenia—Epirubicin—breast cancer	4.17e-05	0.00014	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—breast cancer	4.17e-05	0.00014	CcSEcCtD
Trandolapril—Headache—Paclitaxel—breast cancer	4.16e-05	0.00014	CcSEcCtD
Trandolapril—Hypersensitivity—Docetaxel—breast cancer	4.15e-05	0.00014	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—breast cancer	4.14e-05	0.00014	CcSEcCtD
Trandolapril—Palpitations—Epirubicin—breast cancer	4.11e-05	0.000139	CcSEcCtD
Trandolapril—Loss of consciousness—Epirubicin—breast cancer	4.09e-05	0.000138	CcSEcCtD
Trandolapril—Cough—Epirubicin—breast cancer	4.06e-05	0.000137	CcSEcCtD
Trandolapril—Asthenia—Docetaxel—breast cancer	4.04e-05	0.000136	CcSEcCtD
Trandolapril—Infection—Methotrexate—breast cancer	4.03e-05	0.000136	CcSEcCtD
Trandolapril—Hypersensitivity—Capecitabine—breast cancer	4.02e-05	0.000135	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—breast cancer	4e-05	0.000135	CcSEcCtD
Trandolapril—Pruritus—Docetaxel—breast cancer	3.99e-05	0.000134	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—breast cancer	3.98e-05	0.000134	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—breast cancer	3.98e-05	0.000134	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—breast cancer	3.98e-05	0.000134	CcSEcCtD
Trandolapril—Arthralgia—Epirubicin—breast cancer	3.96e-05	0.000134	CcSEcCtD
Trandolapril—Chest pain—Epirubicin—breast cancer	3.96e-05	0.000134	CcSEcCtD
Trandolapril—Myalgia—Epirubicin—breast cancer	3.96e-05	0.000134	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—breast cancer	3.96e-05	0.000133	CcSEcCtD
Trandolapril—Anxiety—Epirubicin—breast cancer	3.95e-05	0.000133	CcSEcCtD
Trandolapril—Nausea—Paclitaxel—breast cancer	3.95e-05	0.000133	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—breast cancer	3.94e-05	0.000133	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.94e-05	0.000133	CcSEcCtD
Trandolapril—Hyperhidrosis—Methotrexate—breast cancer	3.93e-05	0.000132	CcSEcCtD
Trandolapril—Discomfort—Epirubicin—breast cancer	3.92e-05	0.000132	CcSEcCtD
Trandolapril—Asthenia—Capecitabine—breast cancer	3.91e-05	0.000132	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—breast cancer	3.88e-05	0.000131	CcSEcCtD
Trandolapril—Dry mouth—Epirubicin—breast cancer	3.88e-05	0.000131	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—breast cancer	3.87e-05	0.00013	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—breast cancer	3.87e-05	0.00013	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—breast cancer	3.86e-05	0.00013	CcSEcCtD
Trandolapril—Pruritus—Capecitabine—breast cancer	3.86e-05	0.00013	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—breast cancer	3.86e-05	0.00013	CcSEcCtD
Trandolapril—Diarrhoea—Docetaxel—breast cancer	3.85e-05	0.00013	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—breast cancer	3.81e-05	0.000128	CcSEcCtD
Trandolapril—Oedema—Epirubicin—breast cancer	3.8e-05	0.000128	CcSEcCtD
Trandolapril—Hypotension—Methotrexate—breast cancer	3.79e-05	0.000128	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—breast cancer	3.79e-05	0.000128	CcSEcCtD
Trandolapril—Infection—Epirubicin—breast cancer	3.78e-05	0.000127	CcSEcCtD
Trandolapril—Cough—Doxorubicin—breast cancer	3.76e-05	0.000127	CcSEcCtD
Trandolapril—Shock—Epirubicin—breast cancer	3.74e-05	0.000126	CcSEcCtD
Trandolapril—Diarrhoea—Capecitabine—breast cancer	3.73e-05	0.000126	CcSEcCtD
Trandolapril—Nervous system disorder—Epirubicin—breast cancer	3.73e-05	0.000126	CcSEcCtD
Trandolapril—Dizziness—Docetaxel—breast cancer	3.73e-05	0.000126	CcSEcCtD
Trandolapril—Thrombocytopenia—Epirubicin—breast cancer	3.72e-05	0.000125	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—CXCL8—breast cancer	3.71e-05	0.000485	CbGpPWpGaD
Trandolapril—Tachycardia—Epirubicin—breast cancer	3.71e-05	0.000125	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Methotrexate—breast cancer	3.7e-05	0.000125	CcSEcCtD
Trandolapril—Skin disorder—Epirubicin—breast cancer	3.69e-05	0.000124	CcSEcCtD
Trandolapril—Hyperhidrosis—Epirubicin—breast cancer	3.67e-05	0.000124	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—breast cancer	3.67e-05	0.000124	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—breast cancer	3.67e-05	0.000124	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—breast cancer	3.67e-05	0.000124	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—breast cancer	3.67e-05	0.000124	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—breast cancer	3.65e-05	0.000123	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—breast cancer	3.65e-05	0.000123	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.64e-05	0.000123	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—breast cancer	3.62e-05	0.000122	CcSEcCtD
Trandolapril—Anorexia—Epirubicin—breast cancer	3.62e-05	0.000122	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—breast cancer	3.62e-05	0.000122	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—breast cancer	3.61e-05	0.000122	CcSEcCtD
Trandolapril—Dizziness—Capecitabine—breast cancer	3.61e-05	0.000122	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—breast cancer	3.59e-05	0.000121	CcSEcCtD
Trandolapril—Vomiting—Docetaxel—breast cancer	3.58e-05	0.000121	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—breast cancer	3.57e-05	0.00012	CcSEcCtD
Trandolapril—Rash—Docetaxel—breast cancer	3.55e-05	0.00012	CcSEcCtD
Trandolapril—Hypotension—Epirubicin—breast cancer	3.55e-05	0.00012	CcSEcCtD
Trandolapril—Dermatitis—Docetaxel—breast cancer	3.55e-05	0.00012	CcSEcCtD
Trandolapril—Decreased appetite—Methotrexate—breast cancer	3.53e-05	0.000119	CcSEcCtD
Trandolapril—Headache—Docetaxel—breast cancer	3.53e-05	0.000119	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—breast cancer	3.52e-05	0.000118	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Methotrexate—breast cancer	3.51e-05	0.000118	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—breast cancer	3.5e-05	0.000118	CcSEcCtD
Trandolapril—Infection—Doxorubicin—breast cancer	3.49e-05	0.000118	CcSEcCtD
Trandolapril—Vomiting—Capecitabine—breast cancer	3.47e-05	0.000117	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Epirubicin—breast cancer	3.46e-05	0.000117	CcSEcCtD
Trandolapril—Shock—Doxorubicin—breast cancer	3.46e-05	0.000117	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—breast cancer	3.45e-05	0.000116	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—breast cancer	3.44e-05	0.000116	CcSEcCtD
Trandolapril—Rash—Capecitabine—breast cancer	3.44e-05	0.000116	CcSEcCtD
Trandolapril—Insomnia—Epirubicin—breast cancer	3.44e-05	0.000116	CcSEcCtD
Trandolapril—Dermatitis—Capecitabine—breast cancer	3.44e-05	0.000116	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—breast cancer	3.43e-05	0.000116	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—CTNNB1—breast cancer	3.43e-05	0.000448	CbGpPWpGaD
Trandolapril—Headache—Capecitabine—breast cancer	3.42e-05	0.000115	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—breast cancer	3.42e-05	0.000115	CcSEcCtD
Trandolapril—Paraesthesia—Epirubicin—breast cancer	3.41e-05	0.000115	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—breast cancer	3.4e-05	0.000115	CcSEcCtD
Trandolapril—Dyspnoea—Epirubicin—breast cancer	3.39e-05	0.000114	CcSEcCtD
Trandolapril—Somnolence—Epirubicin—breast cancer	3.38e-05	0.000114	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—breast cancer	3.35e-05	0.000113	CcSEcCtD
Trandolapril—Nausea—Docetaxel—breast cancer	3.35e-05	0.000113	CcSEcCtD
Trandolapril—Feeling abnormal—Methotrexate—breast cancer	3.35e-05	0.000113	CcSEcCtD
Trandolapril—Dyspepsia—Epirubicin—breast cancer	3.34e-05	0.000113	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—breast cancer	3.32e-05	0.000112	CcSEcCtD
Trandolapril—Decreased appetite—Epirubicin—breast cancer	3.3e-05	0.000111	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—breast cancer	3.29e-05	0.000111	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Epirubicin—breast cancer	3.28e-05	0.000111	CcSEcCtD
Trandolapril—Fatigue—Epirubicin—breast cancer	3.28e-05	0.00011	CcSEcCtD
Trandolapril—Constipation—Epirubicin—breast cancer	3.25e-05	0.00011	CcSEcCtD
Trandolapril—Nausea—Capecitabine—breast cancer	3.24e-05	0.000109	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—breast cancer	3.23e-05	0.000109	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—breast cancer	3.21e-05	0.000108	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—breast cancer	3.21e-05	0.000108	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.2e-05	0.000108	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—breast cancer	3.18e-05	0.000107	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—breast cancer	3.16e-05	0.000106	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—breast cancer	3.13e-05	0.000106	CcSEcCtD
Trandolapril—Feeling abnormal—Epirubicin—breast cancer	3.13e-05	0.000106	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—breast cancer	3.13e-05	0.000105	CcSEcCtD
Trandolapril—Gastrointestinal pain—Epirubicin—breast cancer	3.11e-05	0.000105	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—breast cancer	3.09e-05	0.000104	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—breast cancer	3.06e-05	0.000103	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—breast cancer	3.04e-05	0.000102	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—breast cancer	3.03e-05	0.000102	CcSEcCtD
Trandolapril—Urticaria—Epirubicin—breast cancer	3.02e-05	0.000102	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—breast cancer	3.01e-05	0.000101	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	3.01e-05	0.000393	CbGpPWpGaD
Trandolapril—Body temperature increased—Epirubicin—breast cancer	3e-05	0.000101	CcSEcCtD
Trandolapril—Abdominal pain—Epirubicin—breast cancer	3e-05	0.000101	CcSEcCtD
Trandolapril—Hypersensitivity—Methotrexate—breast cancer	2.99e-05	0.000101	CcSEcCtD
Trandolapril—Asthenia—Methotrexate—breast cancer	2.91e-05	9.82e-05	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—breast cancer	2.9e-05	9.76e-05	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—breast cancer	2.88e-05	9.69e-05	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—breast cancer	2.87e-05	9.68e-05	CcSEcCtD
Trandolapril—Hypersensitivity—Epirubicin—breast cancer	2.8e-05	9.43e-05	CcSEcCtD
Trandolapril—Urticaria—Doxorubicin—breast cancer	2.79e-05	9.41e-05	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	2.79e-05	0.000365	CbGpPWpGaD
Trandolapril—Body temperature increased—Doxorubicin—breast cancer	2.78e-05	9.37e-05	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—breast cancer	2.78e-05	9.37e-05	CcSEcCtD
Trandolapril—Diarrhoea—Methotrexate—breast cancer	2.78e-05	9.36e-05	CcSEcCtD
Trandolapril—Asthenia—Epirubicin—breast cancer	2.73e-05	9.19e-05	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	2.72e-05	0.000355	CbGpPWpGaD
Trandolapril—Pruritus—Epirubicin—breast cancer	2.69e-05	9.06e-05	CcSEcCtD
Trandolapril—Dizziness—Methotrexate—breast cancer	2.69e-05	9.05e-05	CcSEcCtD
Trandolapril—Diarrhoea—Epirubicin—breast cancer	2.6e-05	8.76e-05	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—breast cancer	2.59e-05	8.73e-05	CcSEcCtD
Trandolapril—Vomiting—Methotrexate—breast cancer	2.58e-05	8.7e-05	CcSEcCtD
Trandolapril—Rash—Methotrexate—breast cancer	2.56e-05	8.63e-05	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—breast cancer	2.56e-05	8.62e-05	CcSEcCtD
Trandolapril—Headache—Methotrexate—breast cancer	2.54e-05	8.57e-05	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—breast cancer	2.52e-05	8.5e-05	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	2.52e-05	0.00033	CbGpPWpGaD
Trandolapril—Dizziness—Epirubicin—breast cancer	2.51e-05	8.47e-05	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—breast cancer	2.49e-05	8.38e-05	CcSEcCtD
Trandolapril—Vomiting—Epirubicin—breast cancer	2.42e-05	8.14e-05	CcSEcCtD
Trandolapril—Nausea—Methotrexate—breast cancer	2.41e-05	8.13e-05	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—breast cancer	2.41e-05	8.11e-05	CcSEcCtD
Trandolapril—Rash—Epirubicin—breast cancer	2.4e-05	8.07e-05	CcSEcCtD
Trandolapril—Dermatitis—Epirubicin—breast cancer	2.39e-05	8.07e-05	CcSEcCtD
Trandolapril—Headache—Epirubicin—breast cancer	2.38e-05	8.02e-05	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—breast cancer	2.33e-05	7.84e-05	CcSEcCtD
Trandolapril—Nausea—Epirubicin—breast cancer	2.26e-05	7.61e-05	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—breast cancer	2.24e-05	7.53e-05	CcSEcCtD
Trandolapril—Rash—Doxorubicin—breast cancer	2.22e-05	7.47e-05	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—breast cancer	2.21e-05	7.46e-05	CcSEcCtD
Trandolapril—Headache—Doxorubicin—breast cancer	2.2e-05	7.42e-05	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—breast cancer	2.09e-05	7.04e-05	CcSEcCtD
